Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.

Cancer chemotherapy reports. Part 1

Volumn 56, Issue 1, 1972, Pages 95-101

  Moertel, C G ^a   Schutt, A J ^a   Reitemeier, R J ^a   Hahn, R G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADULT; AGED; ALOPECIA; ARTICLE; CYSTITIS; DERMATITIS; DIARRHEA; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; IATROGENIC DISEASE; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NAUSEA; STOMATITIS; THROMBOCYTOPENIA; TIME; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ALKALOIDS; ALOPECIA; ANTINEOPLASTIC AGENTS; CYSTITIS; DERMATITIS; DIARRHEA; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMAN; INJECTIONS, INTRAVENOUS; LEUKOPENIA; MALE; MIDDLE AGE; NAUSEA; STOMATITIS; THROMBOCYTOPENIA; TIME FACTORS; VOMITING;

EID: 0015291595     PISSN: 00690112     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)